07:00 , Oct 20, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Galectin-12 (LGALS12; GAL12) Mouse studies suggest antagonizing LGALS12 could help...